Our response to paper on fish oil and probiotic supplements during pregnancy reducing the risk of food allergies and eczema in children.
Our response to the WHO announcement that the number of measles cases in Europe has risen by 400% in the past year.
Our response to news stories on a new vaccine-based immunotherapy to treat grass pollen allergy
Our response to a paper published in Science on a new approach to develop a universal flu vaccine
The BSI has issued a statement in response to ongoing media stories about the current flu outbreak in the UK.
BSI statement in response to BMJ report on use of animal studies in the development of a TB vaccine.
Our response to the publication of the UK Government's Industrial Strategy
BSI statement in response to news reports of a measles outbreak in Liverpool and Leeds.
The BSI has released a statement in response to the news that Dr Patrick Vallance has been appointed the new governement Chief Scientific Advisor.
The BSI response to the Nobel Prize for Chemistry 2017 being awarded for a technique to allow the imaging of molecules.
27 September 2017
This is the BSI response to the publication of the 2016 - 17 immunisations statistics for England.
A presentation being made at the European Respiratory Society Congress in Milan today has reported on findings from a study examining the use of disinfectant by nurses and their subsequent likelihood of developing chronic obstructive pulmonary disease (COPD).
Our response to the Government commissioned report on the UK's Life Sciences Industrial Strategy
Our response to a study published in the Journal of Immunology looking at how carbon nanoparticles (such as those found in air pollution) can alter structure and function of certain proteins of the immune system.